Since October 2008, the C1-Esterase inhibitor (C1-INH) has been approved in the US for routine prophylaxis against angioedema attacks in adolescents and adults with HAE. Cinryze’s latest approval
Hepatoblastoma is a rare type of primary liver cancer that affects young children and is often diagnosed in children under two. During the SIOPEL-6 clinical trial led by
Semaglutide, which is a human glucagon-like peptide-1 (GLP-1) receptor agonist, was evaluated in comparison to Victoza (1.8mg liraglutide) and placebo in the Pioneer 4 trial and with sitagliptin
However, the company is positive on the outcome of the trial with its final analysis, which is based on survival, delayed due to the unexpected longevity of the
Part of the government’s modern industrial strategy, the Scottish project will secure £13m funding from the Industrial Strategy Challenge Fund. The funding is offered by UK Research and
Germany-based Evotec will also get licenses of a majority of infectious disease research portfolio and initiatives of Sanofi as per the terms of the transaction agreement. Sanofi has
WHIM syndrome is a primary immunodeficiency disease caused by a mutation in the C-X-C receptor type 4 (CXCR4) gene, which results in susceptibility to certain types of infections. The
However, the trial dubbed, Enforce, will be continued to study the drug’s performance in the treatment of episodic cluster headache as planned. Originally, the late-stage trial featured the
The trials, named GEMINI-1 and GEMINI-2, assessed the 2DR against a three-drug regimen of dolutegravir and two nucleoside reverse transcriptase inhibitors in HIV-1 patients with baseline viral loads
The Boston-based clinical-stage biotechnology company had been conducting the mid-stage trials for the oral disintegrating tablet formulation in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). Flex Pharma said
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.